Hepion Pharmaceuticals announces death of director Thomas Adams

Hepion Pharmaceuticals, Inc.

Thomas Adams, Ph.D., passed away on January 9, 2022 due to natural causes.
Dr. Adams served on Hepion's board since September 2016.
No replacement director has been announced as of the press release date.
Company expressed condolences; no other operational changes reported.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Tom Adams

Director

HEPA · Hepion Pharmaceuticals, Inc.

Effective: 2022-01-09
Filed: January 12, 2022, 6:59 PM ET

On January 9, 2022, Dr. Tom Adams, a director of Hepion Pharmaceuticals, Inc., passed away.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Tom Adams departed as Director at Hepion Pharmaceuticals, Inc..

Action: passed away
Role: Director

Exact text from the filing

On January 9, 2022, Dr. Tom Adams, a director of Hepion Pharmaceuticals, Inc., passed away.

View on SEC.gov

Hepion Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-22-003432

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.